Skip to main content
SpringerPlus
Fig. 2 | SpringerPlus

Fig. 2

From: Response-adapted treatment with upfront high-dose chemotherapy followed by autologous stem-cell transplantation rescue or consolidation phase high-dose methotrexate for primary central nervous system lymphoma: a long-term mono-center study

Fig. 2

Kaplan–Meier curves of all patients. a Kaplan–Meier curve shows the median overall survival (OS) of all patients is 41.6 months (95 % CI 21.1–67.6 months). b Kaplan–Meier curve shows the median progression-free survival (PFS) of 27.9 months (95 % CI 14.7–38 months)

Back to article page